Bale TL - Search Results

1

The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.

Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. Bale TL, et al. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3697-702. doi: 10.1073/pnas.0307324101. Epub 2004 Feb 27. Proc Natl Acad Sci U S A. 2004. PMID: 14990799 Free PMC article.

2

Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF. Bale TL, et al. J Neurosci. 2002 Jan 1;22(1):193-9. doi: 10.1523/JNEUROSCI.22-01-00193.2002. J Neurosci. 2002. PMID: 11756502 Free PMC article.

3

Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.

Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, Lee KF. Bale TL, et al. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7734-9. doi: 10.1073/pnas.102187099. Proc Natl Acad Sci U S A. 2002. PMID: 12032352 Free PMC article.

4

A new role for corticotropin-releasing factor receptor-2: suppression of vascularization.

Bale TL, Giordano FJ, Vale WW. Bale TL, et al. Trends Cardiovasc Med. 2003 Feb;13(2):68-71. doi: 10.1016/s1050-1738(02)00214-1. Trends Cardiovasc Med. 2003. PMID: 12586442 Review.

5

Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold.

Bale TL, Anderson KR, Roberts AJ, Lee KF, Nagy TR, Vale WW. Bale TL, et al. Endocrinology. 2003 Jun;144(6):2580-7. doi: 10.1210/en.2002-0091. Endocrinology. 2003. PMID: 12746321

6

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

Bale TL, Vale WW. Bale TL, et al. J Neurosci. 2003 Jun 15;23(12):5295-301. doi: 10.1523/JNEUROSCI.23-12-05295.2003. J Neurosci. 2003. PMID: 12832554 Free PMC article.

7

Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis.

Carlin KM, Vale WW, Bale TL. Carlin KM, et al. Among authors: bale tl. Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3462-7. doi: 10.1073/pnas.0511320103. Epub 2006 Feb 21. Proc Natl Acad Sci U S A. 2006. PMID: 16492754 Free PMC article.

8

CRF and CRF receptors: role in stress responsivity and other behaviors.

Bale TL, Vale WW. Bale TL, et al. Annu Rev Pharmacol Toxicol. 2004;44:525-57. doi: 10.1146/annurev.pharmtox.44.101802.121410. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744257 Review.

9

Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation.

Hao Z, Huang Y, Cleman J, Jovin IS, Vale WW, Bale TL, Giordano FJ. Hao Z, et al. Among authors: bale tl. Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3939-44. doi: 10.1073/pnas.0712366105. Epub 2008 Feb 28. Proc Natl Acad Sci U S A. 2008. PMID: 18308934 Free PMC article.

10

The role of corticotropin-releasing factor receptors in stress and anxiety.

Bale TL, Lee KF, Vale WW. Bale TL, et al. Integr Comp Biol. 2002 Jul;42(3):552-5. doi: 10.1093/icb/42.3.552. Integr Comp Biol. 2002. PMID: 21708750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters